Camosunate is a medication specifically formulated for the treatment of malaria, including in pediatric patients under 1 year of age. It combines active ingredients that effectively target the malaria parasite, providing relief from symptoms and promoting recovery.

Key Features:

Targeted Action: Camosunate contains artemisinin derivatives that rapidly reduce the malaria parasite load in the bloodstream, helping to clear the infection.
Pediatric Formulation: Designed for infants and young children, ensuring safety and efficacy for this vulnerable age group.
Gentle on Young Bodies: Formulated to minimize side effects while effectively treating malaria, making it suitable for young patients.
Convenient Dosing: Available in appropriate formulations for young children, facilitating easy administration.

Very secured payment methods

Shipping will be calculated on checkout

Please note that price may increase due to exchange rate, ensure updated price before making payment